{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:02:59Z","timestamp":1760522579793},"reference-count":31,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biophysical Chemistry"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1016\/j.bpc.2008.01.003","type":"journal-article","created":{"date-parts":[[2008,1,20]],"date-time":"2008-01-20T00:51:08Z","timestamp":1200790268000},"page":"39-46","source":"Crossref","is-referenced-by-count":22,"title":["The psychotropic drug olanzapine (Zyprexa\u00ae) increases the area of acid glycerophospholipid monolayers"],"prefix":"10.1016","volume":"134","author":[{"given":"Signe","family":"Steinkopf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja Katrin","family":"Schelderup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Linn","family":"Gjerde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeanette","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Synn\u00f8ve","family":"Thoresen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anja Underhaug","family":"Gjerde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holm","family":"Holmsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpc.2008.01.003_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/0049-3848(84)90298-6","article-title":"Differential effects of trifluoperazine on arachidonate liberation, secretion and myosin phosphorylation in intact plateletes","volume":"34","author":"Holmsen","year":"1984","journal-title":"Thromb. Res."},{"key":"10.1016\/j.bpc.2008.01.003_bib2","first-page":"307","article-title":"Trifluoperazine specifically stimulated phosphatidate formation without inhibiting arachidonate liberation by phospholipase A2 in thrombin-activated platelets","volume":"64","author":"Holmsen","year":"1990","journal-title":"Thrombos Haemost"},{"key":"10.1016\/j.bpc.2008.01.003_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0014-5793(90)80757-A","article-title":"Evidence that chlorpromazine and prostaglandin E1 but not neomycin inhibits signal transduction in intact human platelets at a level prior to the inositol phospholipid metabolism","volume":"264","author":"Tysnes","year":"1990","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bpc.2008.01.003_bib4","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/0006-2952(92)90104-Q","article-title":"Chlorpromazine increases the turnover of metabolically active phosphoinositides and elevates the steady-state level of phosphatidylinositol-4-phosphate in human platelets","volume":"44","author":"Fr\u00f8lich","year":"1992","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bpc.2008.01.003_bib5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0006-2952(00)00445-7","article-title":"The stimulatory, inhibitory and permeabilizing effects of cationic amphiphilic drugs on thrombin-stimulated human platelets","volume":"60","author":"Tharmapathy","year":"2000","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bpc.2008.01.003_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s002100000339","article-title":"Dopamine receptors in human platelets","volume":"363","author":"Ricci","year":"2001","journal-title":"Naunyn-Schmieberg's Arch. Pharmacol."},{"key":"10.1016\/j.bpc.2008.01.003_bib7","first-page":"583","article-title":"The membrane actions of anesthetics and tranquilizers","volume":"24","author":"Seeman","year":"1972","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.bpc.2008.01.003_bib8","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/0006-2952(86)90269-8","article-title":"Phenothiazine drugs and metabolites: molecular conformation and dopaminergic, \u03b1-adrenergic and muscarinic cholinergic receptor binding","volume":"35","author":"Dahl","year":"1986","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bpc.2008.01.003_bib9","unstructured":"R. Oruch, E. Hodneland, I.F. Pryme and H. Holmsen, Effects of psychotropic drugs on polyphosphoinositide metabolism in human platelets: A result of receptor-independent drug intercalation in the plasma membrane? Biochim. Biophys. Acta. Submitted for publication."},{"key":"10.1016\/j.bpc.2008.01.003_bib10","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0006-2952(01)00542-1","article-title":"Interacction of chlorpromazine with dipalmitoylphosphatidylserine: a monolayer study at room temperatrure","volume":"61","author":"Agas\u00f8ster","year":"2001","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bpc.2008.01.003_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0301-4622(01)00152-1","article-title":"Chlorpromazine associates with phosphatidylserines to cause an increase in the lipids' own interfacial molecular area in a manner similar to increased temperature \u2014 role of the fatty acyl composition","volume":"91","author":"Agas\u00f8ster","year":"2001","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2008.01.003_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0009-3084(01)00175-X","article-title":"Comparison of the effects of clozapine, chlorpromazine and haloperidol on membrane lateral heterogeneity","volume":"112","author":"Jutila","year":"2001","journal-title":"Chem. Phys. Lip."},{"key":"10.1016\/j.bpc.2008.01.003_bib13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bpc.2003.10.020","article-title":"Interaction of two phenothiazine derivatives with phospholipid monolayers","volume":"109","author":"Hidalgo","year":"2004","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2008.01.003_bib14","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1515\/znc-2001-9-1024","article-title":"Expansion of phosphatidylcholine and phosphatidylserine\/phosphatidylcholine monolayers by differently charged amphiphiles","volume":"56","author":"Bialkowska","year":"2001","journal-title":"Z. Naturforsch."},{"key":"10.1016\/j.bpc.2008.01.003_bib15","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1021\/la061628b","article-title":"Trifluoperazine causes disturbance in glycerophospholipid monolayers containing phosphatidylserine (PS): effects of Ph, acyl unsaturation and proportion of PS","volume":"23","author":"Broniec","year":"2007","journal-title":"Langmuir"},{"issue":"1","key":"10.1016\/j.bpc.2008.01.003_bib16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0005-2736(00)00125-5","article-title":"Chlorpromazine interaction with glycerophospholipid liposomes studied by magic angle spinning solid state (13)C-NMR and differential scanning calorimetry","volume":"1464","author":"Nerdal","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"issue":"1\u20133","key":"10.1016\/j.bpc.2008.01.003_bib17","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbalip.2004.01.004","article-title":"Chlorpromazine interaction with phosphatidylserines: a (13)C and (31)P solid-state NMR study","volume":"1682","author":"Underhaug Gjerde","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bpc.2008.01.003_bib18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.bpc.2005.05.002","article-title":"Importance of polyunsaturated acyl chains in chlorpromazine interaction with phosphatidylserines: a 13C and 31P solid-state NMR study","volume":"117","author":"Chen","year":"2005","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2008.01.003_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bpc.2005.11.007","article-title":"Existence of lipid microdomains in bilayer of dipalmitoyl phosphatidylcholine (DPPC) and 1-stearoyl-2-docosahexenoyl phosphatidylserine (SDPS) and their perturbation by chlorpromazine: a 13C and 31P solid-state NMR study","volume":"120","author":"Song","year":"2005","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.bpc.2008.01.003_bib20","unstructured":"A.U. Gjerde, H. Holmsen, Chlorpromazine interaction with phospholipids membranes: a fluorescence spectroscopy study. Fluorescence, submitted for publication."},{"key":"10.1016\/j.bpc.2008.01.003_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors. Focus on the newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.bpc.2008.01.003_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2003","journal-title":"Can. J. Psychiatry."},{"key":"10.1016\/j.bpc.2008.01.003_bib23","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/S0028-3908(02)00018-7","article-title":"Effects of atypical antipsychotics on vertebrate neuromuscular transmission","volume":"42","author":"Nguyen","year":"2002","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bpc.2008.01.003_bib24","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00726-006-0312-3","article-title":"Chlorpromazine, clozapine and olanzapine inhibit anionic amino acid transport in cultured human fibroblasts","volume":"32","author":"Marchesi","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.bpc.2008.01.003_bib25","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.pnpbp.2006.04.025","article-title":"Serum creatine kinase levels in chronic psychosis patients \u2014 a comparison between atypical and conventional antipsychotics","volume":"30","author":"Melkersson","year":"2006","journal-title":"Prog. Neuropshycopharmacol. Biol. Psych."},{"year":"1999","series-title":"Material Safety Data Sheet","author":"Olanzapine","key":"10.1016\/j.bpc.2008.01.003_bib26"},{"key":"10.1016\/j.bpc.2008.01.003_bib27","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.2042-7158.1993.tb05660.x","article-title":"Partition of dopamine antagonists into synthetic lipid bilayers: the effect of membrane structure and composition","volume":"45","author":"Sarmento","year":"1993","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.bpc.2008.01.003_bib28","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/0005-2736(86)90037-4","article-title":"Partition of chlorpromazine into lipid bilayer membranes: the effect of membrane structure and composition","volume":"856","author":"Luxnat","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bpc.2008.01.003_bib29","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1248\/cpb.53.147","article-title":"Effects of phosphatidylserine and phosphatidylethanolamine content on partitioning of trifluoperazine and chlorpromazine between phosphatidylcholine-aminophospholipid bilayer vesicles and water studied by second derivative spectrophotometry","volume":"53","author":"Takegami","year":"2005","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"key":"10.1016\/j.bpc.2008.01.003_bib30","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.regpep.2005.11.003","article-title":"Interactions of chromogranin-derived vasostatins and monolayers of phosphatidylserine, phosphatidylcholine and phosphatidylethanolamine","volume":"134","author":"Blois","year":"2006","journal-title":"Regul. Pept."},{"key":"10.1016\/j.bpc.2008.01.003_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.bpc.2008.01.002","article-title":"Olanzapine interaction with dipalmitoylphosphatidyl choline (DPPC) and 1-palmiotyl-2-oleoyl phosphatidylserine (POPS) bilayer: a 13C and 31P solid-state NMR study","volume":"134","author":"Song","year":"2008","journal-title":"Biophys. Chem."}],"container-title":["Biophysical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462208000069?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301462208000069?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T22:48:11Z","timestamp":1684190891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301462208000069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":31,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["S0301462208000069"],"URL":"https:\/\/doi.org\/10.1016\/j.bpc.2008.01.003","relation":{},"ISSN":["0301-4622"],"issn-type":[{"type":"print","value":"0301-4622"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}